BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6488678)

  • 1. Effects of nadolol and propranolol on plasma lidocaine clearance.
    Schneck DW; Luderer JR; Davis D; Vary J
    Clin Pharmacol Ther; 1984 Nov; 36(5):584-7. PubMed ID: 6488678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lidocaine elimination: effects of metoprolol and of propranolol.
    Conrad KA; Byers JM; Finley PR; Burnham L
    Clin Pharmacol Ther; 1983 Feb; 33(2):133-8. PubMed ID: 6822025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impairment of lignocaine clearance by propranolol--major contribution from enzyme inhibition.
    Bax ND; Tucker GT; Lennard MS; Woods HF
    Br J Clin Pharmacol; 1985 May; 19(5):597-603. PubMed ID: 2860914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the effects of intravenous propranolol and nadolol on the renal response to hypertonic saline infusion.
    Waller DG; Mihindukulasuriya J; Warren DJ
    Br J Clin Pharmacol; 1985 Jan; 19(1):37-43. PubMed ID: 2858216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do beta blockers differ in their effects on hepatic microsomal enzymes and liver blood flow?
    Parker G; Ene MD; Daneshmend TK; Roberts CJ
    J Clin Pharmacol; 1984; 24(11-12):493-9. PubMed ID: 6150945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of propranolol and nadolol on renal blood flow in normal rats and rats with congestive heart failure.
    Brenner BM; Duchin KL; Ichikawa I; Pfeffer J; Pfeffer M
    Am Heart J; 1984 Oct; 108(4 Pt 2):1144-7. PubMed ID: 6148876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dl-propranolol on lidocaine disposition in the perfused rat liver.
    Vu VT; Chen CP
    Drug Metab Dispos; 1982; 10(4):350-5. PubMed ID: 6126333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of kinetic interactions of nadolol and propranolol with cimetidine.
    Duchin KL; Stern MA; Willard DA; McKinstry DN
    Am Heart J; 1984 Oct; 108(4 Pt 2):1084-6. PubMed ID: 6148867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of route of administration and blood flow on hepatic drug elimination.
    Shand DG; Kornhauser DM; Wilkinson GR
    J Pharmacol Exp Ther; 1975 Dec; 195(3):424-32. PubMed ID: 1195129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of propranolol and pindolol on plasma lignocaine clearance in man.
    Svendsen TL; Tangø M; Waldorff S; Steiness E; Trap-Jensen J
    Br J Clin Pharmacol; 1982; 13(Suppl 2):223S-226S. PubMed ID: 7104144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The reduction of lidocaine clearance by dl-propranolol: an example of hemodynamic drug interaction.
    Branch RA; Shand DG; Wilkinson GR; Nies AS
    J Pharmacol Exp Ther; 1973 Feb; 184(2):515-9. PubMed ID: 4688187
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of four beta-blockers as assessed by 24-hour ECG recording.
    Escoubet B; Leclercq JF; Maison-Blanche P; Poirier JM; Gourmel B; Delhotal-Landes B; Coumel P
    Clin Pharmacol Ther; 1986 Apr; 39(4):361-8. PubMed ID: 3956052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of nadolol and propranolol on renal function in hypertensive patients with moderately impaired renal function.
    Pun KK; Yeung CK; Chan MK
    Br J Clin Pharmacol; 1985 Oct; 20(4):401-4. PubMed ID: 3907676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. beta-Adrenoceptor-blocking agents and the kidney: effect of nadolol and propranolol on the renal circulation.
    Hollenberg NK; Adams DF; McKinstry DN; Williams GH; Borucki LJ; Sullivan JM
    Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):219S-225S. PubMed ID: 37877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nadolol, propranolol, and thyroid hormones: evidence for a membrane-stabilizing action of propranolol.
    Reeves RA; From GL; Paul W; Leenen FH
    Clin Pharmacol Ther; 1985 Feb; 37(2):157-61. PubMed ID: 3967459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lidocaine kinetics predicted by indocyanine green clearance.
    Zito RA; Reid PR
    N Engl J Med; 1978 May; 298(21):1160-3. PubMed ID: 651945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of histamine-2 receptor blockade on lidocaine kinetics.
    Jackson JE; Bentley JB; Glass SJ; Fukui T; Gandolfi AJ; Plachetka JR
    Clin Pharmacol Ther; 1985 May; 37(5):544-8. PubMed ID: 3987178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of nadolol on liver haemodynamics and function in patients with cirrhosis.
    Merkel C; Sacerdoti D; Finucci GF; Zuin R; Bazzerla G; Bolognesi M; Gatta A
    Br J Clin Pharmacol; 1986 Jun; 21(6):713-9. PubMed ID: 3741719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of nadolol beta-blockade on blood pressure in hypertension.
    Duchin KL; Vukovich RA; Dennick LG; Groel JT; Willard DA
    Clin Pharmacol Ther; 1980 Jan; 27(1):57-63. PubMed ID: 6101312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased toxicity and reduced clearance of lidocaine by cimetidine.
    Feely J; Wilkinson GR; McAllister CB; Wood AJ
    Ann Intern Med; 1982 May; 96(5):592-4. PubMed ID: 7073151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.